Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

CAFFEINE CITRATE INJECTION USP 20 MG — DIN 02526778

CAFFEINE CITRATE : 20 MG · OMEGA LABORATORIES LIMITED · SOLUTION · wholesale supply in Canada

Health Canada status: MARKETED

What is CAFFEINE CITRATE INJECTION USP?

CAFFEINE CITRATE INJECTION USP 20 MG contains CAFFEINE CITRATE : 20 MG. It is listed in the Health Canada Drug Product Database under DIN 02526778, held by OMEGA LABORATORIES LIMITED, supplied as SOLUTION for INTRAVENOUS administration. Health Canada currently lists it as marketed, status dated 11-Jul-2023. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

How much does Caffeine cost around the world?

Caffeine is listed on 6 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.

What a market publishes matters more than the number it publishes. Greece publishes a producer price (ex-factory); Saudi Arabia publishes a public; South Africa publishes a single exit price. Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.

MarketPrice basis published thereBrandsPacks listedRange
South Africasingle exit price4183ZAR███.██
Saudi Arabiapublic912SAR███.██
United Kingdomhospital55GBP███.██
United Arab Emiratespublic22AED███.██
Greeceproducer price (ex-factory)22EUR███.██
United Statesacquisition11USD███.██

105 pack listings across 60 brand entries and 5 price bases, refreshed 03 Sep 2026. Ranges span every Caffeine pack in that market, so a high figure is usually a larger pack rather than the same product.

Figures are held for the Nexara team. Cross-market prices are published on incompatible bases and are not an offer, a landed cost, or a guide to what any buyer can obtain. Nexara publishes which markets list the product and on what basis; the numbers stay internal.

Team sign-in

Canada publishes no comparable public list price. For a delivered Canadian price on a licensed account, verify your licence — it takes about a minute.

Ask Nexara for a landed Canadian price

Is there a generic Caffeine in Canada, and who makes it?

Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.

9 holders have a Canadian DIN containing Caffeine, across 11 DINs, of which 3 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.

Market authorization holderDINsMarketedBrand namesPosition
OMEGA LABORATORIES LIMITED22CAFFEINE CITRATE INJECTION USP, CAFFEINE CITRATE ORAL SOLUTION USPSourceable in Canada
CHIESI FARMACEUTICI S.P.A.11PEYONASourceable in Canada
SUN LABS LTD20ALERT AID CAFFEINE CAPSULES 175MG, ALERT AID CAFFEINE TABLETS 175MGNo marketed DIN
ADDED DIMENSIONS10CAFFEINENo marketed DIN
ALVA-AMCO PHARMACAL COMPANIES, LLC10DIURETTE WATER PILLSNo marketed DIN
D & E PHARMACEUTICALS INC.10DESTIM - TAB 200MGNo marketed DIN
NUTRIBON (1986) INC.10ALERT TAB 100MGNo marketed DIN
SUGARLOAF SPRING RAIN INTERNATIONAL LTD.10SUGARLOAF SPRING CAFFEINE, CAFFEINATED SPRING WATERNo marketed DIN
UPPER 49TH IMPORTS INC. 2715 Bristol Circle, Unit #2 Oakville Ontario Canada L6H 6X510PHENFREE CAFFEINE 100MG CAPSULESNo marketed DIN

Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.

How is it supplied and stored?

Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.

Strength on the label20 MG
Dosage formSOLUTION
RouteINTRAVENOUS

Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.

Substance and classification

Active substanceCaffeine
ATC codeN06BC01
AHFS class20:12.04.14
Biosimilar biologicNo

Confirm the pack and get a price

Health Canada record and identifiers

The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.

DIN (8-digit, as used in ordering)02526778
DIN (unpadded, as printed on some documents)2526778
Brand nameCAFFEINE CITRATE INJECTION USP
Generic / active ingredientCAFFEINE CITRATE : 20 MG
Market authorization holderOMEGA LABORATORIES LIMITED
Health Canada schedulePrescription
ATC codeN06BC01
ATC anatomical main groupN — Nervous system
ATC therapeutic subgroupN06BC
Current statusMARKETED
Status date11-Jul-2023
Original market date2023-11-01 00:00:00
Status sourceLive Health Canada DPD sync

Verify on the primary sources

Health Canada DPD record Approved product monograph (PDF)

Is Caffeine in shortage in Canada?

A Canadian shortage report is on file for a product containing this molecule: Resolved — reported by OMEGA LABORATORIES LIMITED, last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.

Check availability for CAFFEINE CITRATE INJECTION USP

What can be used instead?

Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.

1 · Same molecule, other Canadian presentations

3 of 11 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.

ProductStrengthFormHolderHealth Canada statusDIN
CAFFEINE CITRATE ORAL SOLUTION USP20 MGSOLUTIONOMEGA LABORATORIES LIMITEDMARKETED02526751
PEYONA20 MGSOLUTIONCHIESI FARMACEUTICI S.P.A.MARKETED02496771
ALERT AID CAFFEINE CAPSULES 175MG175 MGCAPSULESUN LABS LTDCANCELLED POST MARKET01941089
ALERT AID CAFFEINE TABLETS 175MG175 MGTABLETSUN LABS LTDCANCELLED POST MARKET01941100
ALERT TAB 100MG100 MGTABLETNUTRIBON (1986) INC.CANCELLED POST MARKET01943642
CAFFEINE200 MGTABLETADDED DIMENSIONSCANCELLED POST MARKET02229824
DESTIM - TAB 200MG200 MGTABLETD & E PHARMACEUTICALS INC.CANCELLED POST MARKET02130521
DIURETTE WATER PILLS200 MGTABLETALVA-AMCO PHARMACAL COMPANIES, LLCCANCELLED PRE MARKET02238753
PHENFREE CAFFEINE 100MG CAPSULESStrengthCapsuleUPPER 49TH IMPORTS INC. 2715 Bristol Circle, Unit #2 Oakville Ontario Canada L6H 6X5CANCELLED POST MARKET02239784
SUGARLOAF SPRING CAFFEINE, CAFFEINATED SPRING WATER50 MGLIQUIDSUGARLOAF SPRING RAIN INTERNATIONAL LTD.CANCELLED POST MARKET02237490

2 · Same class — other molecules in ATC N06BC

MoleculeCanadian brandsDINsMarketedSourceable
CaffeineALERT AID CAFFEINE CAPSULES 175MG · ALERT AID CAFFEINE TABLETS 175MG · ALERT TAB 100MG · CAFFEINE · +7 more113Yes

A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.

3 · Adjacent classes in ATC N06B

ATC subgroupMoleculesDINsMarketed
N06BAAmfetamine · Atomoxetine · Dexamfetamine · Dexmethylphenidate · Lisdexamfetamine · +3 more351215
N06BXIdebenone · Other Psychostimulants30

4 · Fixed-dose combinations with Canadian supply

ProductActive ingredientsHolderStatusDIN
DYANAVEL XRAMPHETAMINE (AMPHETAMINE (COMPLEXED WITH SODIUM POLYSTYRENE SULFONATE), AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE) : 5 MGKYE PHARMACEUTICALS INC.MARKETED02559803

Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.

What else is CAFFEINE CITRATE INJECTION USP called?

The same molecule, Caffeine, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:

NameScriptRegistered in
Adco-DolLatinSouth Africa
Dynapayne TabletsLatinSouth Africa
LenadolLatinSouth Africa
LenapainLatinSouth Africa
PynstopLatinSouth Africa
SyndolLatinSouth Africa
Tenston SA CapsulesLatinSouth Africa
Tenston SA TabletsLatinSouth Africa
BetapynLatinSouth Africa
CodoxolLatinSouth Africa
PharmadolLatinSouth Africa
SedinolLatinSouth Africa
Spectrapain ForteLatinSouth Africa
Spectrapain Forte TLatinSouth Africa
ADOL EXTRA CAPLETSLatinSaudi Arabia

Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.

How can I get it?

Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.

Request a quote for CAFFEINE CITRATE INJECTION USP

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Why is there no price on this page?

Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Sources and disclaimer

Product data sourced from the Health Canada Drug Product Database and the approved product monograph (PDF). Health Canada status reconciled against the live DPD sync. Last reviewed 10 Sep 2026.

Nothing on this page is medical advice. Nexara Health is a licensed wholesale distributor and supplies licensed entities only; consumer orders are routed to a partner pharmacy. Alternatives tables describe supply, not clinical equivalence.

Health Canada Drug Product Database (DPD), DIN 02526778. Last reviewed 2026-09-10. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.